Huang S, Bian Y, Huang C, Miao L
Eur J Drug Metab Pharmacokinet. 2022; 47(6):761-775.
PMID: 35915365
DOI: 10.1007/s13318-022-00786-5.
Megias-Vericat J, Martinez-Cuadron D, Solana-Altabella A, Poveda J, Montesinos P
Pharmaceutics. 2022; 14(4).
PMID: 35456712
PMC: 9030330.
DOI: 10.3390/pharmaceutics14040878.
di Francia R, Crisci S, De Monaco A, Cafiero C, Re A, Iaccarino G
Cancers (Basel). 2021; 13(5).
PMID: 33669053
PMC: 7956511.
DOI: 10.3390/cancers13050966.
Herold N, Rudd S, Sanjiv K, Kutzner J, Bladh J, Paulin C
Cell Cycle. 2017; 16(11):1029-1038.
PMID: 28436707
PMC: 5499833.
DOI: 10.1080/15384101.2017.1314407.
Herold N, Rudd S, Ljungblad L, Sanjiv K, Hed Myrberg I, Paulin C
Nat Med. 2017; 23(2):256-263.
PMID: 28067901
DOI: 10.1038/nm.4265.
SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.
Wan H, Zhu J, Chen F, Xiao F, Huang H, Han X
J Exp Clin Cancer Res. 2014; 33:90.
PMID: 25398670
PMC: 4234887.
DOI: 10.1186/s13046-014-0090-9.
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.
Ogbomo H, Michaelis M, Klassert D, Doerr H, Cinatl Jr J
Neoplasia. 2008; 10(12):1402-10.
PMID: 19048119
PMC: 2586691.
DOI: 10.1593/neo.08972.
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
Bhatla D, Gerbing R, Alonzo T, Conner H, Ross J, Meshinchi S
Br J Haematol. 2008; 144(3):388-94.
PMID: 19036079
PMC: 3083240.
DOI: 10.1111/j.1365-2141.2008.07461.x.
The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.
Harris A, Grahame-Smith D
Cancer Chemother Pharmacol. 1982; 9(1):30-5.
PMID: 6958391
DOI: 10.1007/BF00296758.
Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.
Wiley J, Jones S, Sawyer W, Paterson A
J Clin Invest. 1982; 69(2):479-89.
PMID: 6948829
PMC: 370998.
DOI: 10.1172/jci110472.
Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
Harris A, Grahame-Smith D
Cancer Chemother Pharmacol. 1981; 5(3):185-92.
PMID: 6945922
DOI: 10.1007/BF00258478.
Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
Potter C, BUNCH C
Br J Cancer. 1980; 41(6):985-8.
PMID: 6932908
PMC: 2010366.
DOI: 10.1038/bjc.1980.178.
Clinical pharmacokinetics of commonly used anticancer drugs.
Balis F, Holcenberg J, Bleyer W
Clin Pharmacokinet. 1983; 8(3):202-32.
PMID: 6189661
DOI: 10.2165/00003088-198308030-00002.
The immunosuppressive activity of adamantoyl cytarabine. 3. Immunosuppressive specificity in rats.
Gray G, Mickelson M
Immunology. 1970; 19(3):417-28.
PMID: 5471827
PMC: 1455691.
[Autoradiographic and enzyme-chemical studies of the DNA synthesis in leukemia cells. II. Thymidine-kinase and 3H-thymidine labelling index under cytostatic therapy].
Wilmanns W, HARTJE J
Klin Wochenschr. 1970; 48(13):788-94.
PMID: 5286418
DOI: 10.1007/BF01494494.
Enzyme assays in malignant disease.
Cameron C
J Clin Pathol Suppl (Assoc Clin Pathol). 1970; 4:80-4.
PMID: 4949710
PMC: 1176289.
DOI: 10.1136/jcp.s1-4.1.80.
Predictive tests in cancer. Tuesday 9 April 1974.
Hall T
Br J Cancer. 1974; 30(2):191-8.
PMID: 4608305
PMC: 2009241.
DOI: 10.1038/bjc.1974.181.
Proceedings: Lack of synergy between n-methyl-N-nitrosourea (MNU) and cyclophosphamide (CP) in rat urinary bladder.
Wakefield J, Hicks R
Br J Cancer. 1974; 30(2):180.
PMID: 4419398
PMC: 2009240.
DOI: 10.1038/bjc.1974.156.
Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.
Preisler H, Rustum Y, Azarnia N, Priore R
Cancer Chemother Pharmacol. 1987; 19(1):69-74.
PMID: 3815728
DOI: 10.1007/BF00296260.
Arabinofuranosyl nucleosides induce common fragile sites.
Leonard J, Leonard R, Thompson K
Hum Genet. 1988; 79(2):157-62.
PMID: 3134289
DOI: 10.1007/BF00280556.
